Literature DB >> 28931001

An Automated Rapid Iterative Negative Geotaxis Assay for Analyzing Adult Climbing Behavior in a Drosophila Model of Neurodegeneration.

Wenze Cao1, Li Song1, Jingjing Cheng1, Na Yi1, Luyi Cai1, Fu-de Huang2, Margaret Ho3.   

Abstract

Neurodegenerative diseases are frequently associated with a progressive loss of movement ability, reduced life span, and age-dependent neurodegeneration. To understand the mechanism of these cellular events, and their causal relationships with each other, Drosophila melanogaster, with its sophisticated genetic tools and diverse behavioral features, are used as disease models for assessing neurodegenerative phenotypes. Here we describe a high-throughput method to analyze Drosophila adult negative geotaxis behavior, as an indication for possible motor defects associated with neurodegeneration. An automated machine is designed and developed to drive fly synchronization using an initial electric impulse, later allowing the recording of negative geotaxis behavior over a course of secs to mins. Images from the digitally recorded video are then processed with the self-designed RflyDetection software for statistical data manipulation. Different from the manually controlled negative geotaxis assay based on single fly, this precise, fast, and high-throughput protocol allows data acquisition from more than hundreds of flies simultaneously, providing an efficient approach to advance our understanding in the underlying mechanism of locomotor deficits associated with neurodegeneration.

Entities:  

Mesh:

Year:  2017        PMID: 28931001      PMCID: PMC5752225          DOI: 10.3791/56507

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila.

Authors:  Julia Warner Gargano; Ian Martin; Poonam Bhandari; Michael S Grotewiel
Journal:  Exp Gerontol       Date:  2005-03-19       Impact factor: 4.032

2.  Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease.

Authors:  Li Song; Yijing He; Jiayao Ou; Yongbo Zhao; Ruoyu Li; Jingjing Cheng; Chin-Hsien Lin; Margaret S Ho
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

3.  Automated rapid iterative negative geotaxis assay and its use in a genetic screen for modifiers of Aβ(42)-induced locomotor decline in Drosophila.

Authors:  Haiyan Liu; Meng Han; Qingyi Li; Xiao Zhang; Wen-An Wang; Fu-De Huang
Journal:  Neurosci Bull       Date:  2015-06-15       Impact factor: 5.203

4.  Downregulation of RBO-PI4KIIIα Facilitates Aβ42 Secretion and Ameliorates Neural Deficits in Aβ42-Expressing Drosophila.

Authors:  Xiao Zhang; Wen-An Wang; Li-Xiang Jiang; Hai-Yan Liu; Bao-Zhu Zhang; Nastasia Lim; Qing-Yi Li; Fu-De Huang
Journal:  J Neurosci       Date:  2017-04-19       Impact factor: 6.167

5.  Methods to assay Drosophila behavior.

Authors:  Charles D Nichols; Jaime Becnel; Udai B Pandey
Journal:  J Vis Exp       Date:  2012-03-07       Impact factor: 1.355

6.  Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders.

Authors:  Surya T Madabattula; Joel C Strautman; Andrew M Bysice; Julia A O'Sullivan; Alaura Androschuk; Cory Rosenfelt; Kacy Doucet; Guy Rouleau; Francois Bolduc
Journal:  J Vis Exp       Date:  2015-06-13       Impact factor: 1.355

7.  SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.

Authors:  Yijun Shen; Yiling Xia; Shiquan Meng; Nastasia K H Lim; Wenan Wang; Fude Huang
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  A single dopamine pathway underlies progressive locomotor deficits in a Drosophila model of Parkinson disease.

Authors:  Thomas Riemensperger; Abdul-Raouf Issa; Ulrike Pech; Hélène Coulom; Mỹ-Vân Nguyễn; Marlène Cassar; Mélanie Jacquet; André Fiala; Serge Birman
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

9.  An automated climbing apparatus to measure chemotherapy-induced neurotoxicity in Drosophila melanogaster.

Authors:  Jewel L Podratz; Nathan P Staff; Joshua B Boesche; Nicholas J Giorno; Matthew E Hainy; Shaun A Herring; Michael T Klennert; Christian Milaster; Steve E Nowakowski; Randall G Krug; Ying Peng; Anthony J Windebank
Journal:  Fly (Austin)       Date:  2013-05-21       Impact factor: 2.160

10.  Assaying locomotor, learning, and memory deficits in Drosophila models of neurodegeneration.

Authors:  Yousuf O Ali; Wilfredo Escala; Kai Ruan; R Grace Zhai
Journal:  J Vis Exp       Date:  2011-03-11       Impact factor: 1.355

  10 in total
  5 in total

1.  FreeClimber: automated quantification of climbing performance in Drosophila.

Authors:  Adam N Spierer; Denise Yoon; Chen-Tseh Zhu; David M Rand
Journal:  J Exp Biol       Date:  2021-01-15       Impact factor: 3.312

2.  dCubilin- or dAMN-mediated protein reabsorption in Drosophila nephrocytes modulates longevity.

Authors:  Xiaoming Feng; Xizhen Hong; Qiuxia Fan; Liting Chen; Jing Li; Juan Deng; Siqiao Gong; Fan Fan Hou; Fujian Zhang
Journal:  Dis Model Mech       Date:  2021-09-21       Impact factor: 5.758

Review 3.  Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis.

Authors:  Yohei Nitta; Atsushi Sugie
Journal:  Fly (Austin)       Date:  2022-12       Impact factor: 1.143

4.  The Drosophila melanogaster Levodopa-Induced Depression Model Exhibits Negative Geotaxis Deficits and Differential Gene Expression in Males and Females.

Authors:  Thiago C Moulin; Federico Ferro; Angela Hoyer; Pierre Cheung; Michael J Williams; Helgi B Schiöth
Journal:  Front Neurosci       Date:  2021-05-17       Impact factor: 4.677

5.  Two oppositely-charged sf3b1 mutations cause defective development, impaired immune response, and aberrant selection of intronic branch sites in Drosophila.

Authors:  Bei Zhang; Zhan Ding; Liang Li; Ling-Kun Xie; Yu-Jie Fan; Yong-Zhen Xu
Journal:  PLoS Genet       Date:  2021-11-01       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.